Literature DB >> 2030002

Immunology and the liver.

M Peters1, J Vierling, M E Gershwin, D Milich, F V Chisari, J H Hoofnagle.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 2030002

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  27 in total

1.  High-dose Borna disease virus infection induces a nucleoprotein-specific cytotoxic T-lymphocyte response and prevention of immunopathology.

Authors:  E Furrer; T Bilzer; L Stitz; O Planz
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

2.  Mutations in hepatitis B virus core regions correlate with hepatocellular injury in Chinese patients with chronic hepatitis B.

Authors:  Hiroto Tanaka; Hiroki Ueda; Hiroko Hamagami; Susumu Yukawa; Masakazu Ichinose; Motoshige Miyano; Keiji Mimura; Iwao Nishide; Bo-Xin Zhang; Su-Wen Wang; Shi-Oing Zhou; Bei-Hai Li
Journal:  World J Gastroenterol       Date:  2005-08-14       Impact factor: 5.742

3.  Pathogenic role of B cells in anti-CD40-induced necroinflammatory liver disease.

Authors:  Kiminori Kimura; Hisataka Moriwaki; Masahito Nagaki; Masanao Saio; Yasunari Nakamoto; Makoto Naito; Kazuo Kuwata; Francis V Chisari
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

Review 4.  Interferon in the management of chronic hepatitis B.

Authors:  R P Perrillo
Journal:  Dig Dis Sci       Date:  1993-04       Impact factor: 3.199

5.  HLA expression in hepatocellular carcinoma cell lines.

Authors:  A A Wadee; A Paterson; K A Coplan; S G Reddy
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

Review 6.  Risks and benefits of interferon-alpha in the treatment of hepatitis.

Authors:  M Pardo; E Marriott; M C Moliner; J A Quiroga; V Carreño
Journal:  Drug Saf       Date:  1995-11       Impact factor: 5.606

7.  Neutralizing antibodies in persistent borna disease virus infection: prophylactic effect of gp94-specific monoclonal antibodies in preventing encephalitis.

Authors:  E Furrer; T Bilzer; L Stitz; O Planz
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

Review 8.  Mouse models for therapeutic vaccination against hepatitis B virus.

Authors:  Claudia Dembek; Ulrike Protzer
Journal:  Med Microbiol Immunol       Date:  2014-12-19       Impact factor: 3.402

9.  Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV.

Authors:  M J Koziel; D Dudley; N Afdhal; Q L Choo; M Houghton; R Ralston; B D Walker
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

10.  Purification and characterization of a naturally processed hepatitis B virus peptide recognized by CD8+ cytotoxic T lymphocytes.

Authors:  S L Tsai; M H Chen; C T Yeh; C M Chu; A N Lin; F H Chiou; T H Chang; Y F Liaw
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.